John Eunice G, Domingo Liezl T
Department of Pediatrics, Division of Pediatric Nephrology, University of Illinois at Chicago, Chicago, Illinois, USA.
Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois, USA.
Int J Prev Med. 2014 Mar;5(Suppl 1):S25-38.
Hypertension after pediatric renal transplant is a common and important risk factor for graft loss and patient survival. The mechanism of post kidney transplant hypertension is complex and multifactorial. Control of blood pressure in renal transplant patients is important but often times blood pressures remain uncontrolled. The management of hypertension and obesity in pediatric kidney transplant patients is based on the pathophysiology. Compared to the general pediatric hypertensive population, special attention needs to be focused on the additional impact of immunosuppressive medications side effects and interactions, recurrent disease, and donor and recipient comorbidities such as obesity on blood pressure control with thoughtful consideration of the risk of graft failure. In general, there is a need for prospective studies in pediatric kidney transplant patients to understand the pathophysiology of hypertension and obesity and the appropriate approach to achieve a balance between the primary need to avoid rejection and the need to lower blood pressure and prevent obesity.
小儿肾移植后高血压是移植肾丢失和患者生存的常见且重要的危险因素。肾移植后高血压的机制复杂且具有多因素性。控制肾移植患者的血压很重要,但血压往往仍无法得到控制。小儿肾移植患者高血压和肥胖的管理基于病理生理学。与一般小儿高血压人群相比,需要特别关注免疫抑制药物副作用和相互作用、疾病复发以及供体和受体合并症(如肥胖)对血压控制的额外影响,并慎重考虑移植肾失败的风险。总体而言,需要对小儿肾移植患者进行前瞻性研究,以了解高血压和肥胖的病理生理学,以及在避免排斥反应的首要需求与降低血压和预防肥胖的需求之间取得平衡的适当方法。